Latest News
The Disruption House (TDH), a financial technology benchmarking and data analytics business, has closed a significant funding round and created an executive advisory board.
The funding was raised from a small group of private investors and will enable the firm to complete production of their unique benchmarking and performance tracking platform.
The new executive advisory team consists of Piers Hedley, Chris Justice and Clare Walsh. Piers is a leading strategy advisor to UHNW Families and fast growing businesses as well as being a successful private investor. He brings over 30 years’ experience of helping many businesses to achieve
AnaCap Financial Partners (AnaCap), a European financial services private equity firm, is rebranding its Barclays France business as Milleis Banque (Milleis) with immediate effect.
This follows the successful completion of the acquisition of Barclays’ French retail, wealth and investment management operations (including subsequent regulatory approval) in September 2017.
The rebranding exercise is designed to reflect both the expansion and simplification of its product range, further bringing Milleis in line with the needs and expectations of its broadening customer base. The product development initiative was started in September 2017 and includes to date the introduction of new life insurance policies
Ian Macleod, has joined the board of business angel investment syndicate Archangels, succeeding Geoff Ball, who has retired after seven years.
Archangels’ members invest in, and mentor, promising start-up and early stage companies from Scotland’s vibrant technology and life sciences sectors.
Ian Macleod had a long career as a financial analyst, specialising in electronics and telecoms, initially with Capel Cure Myers and subsequently with decade long spells at NatWest Markets and Jefferies. During most of this period he was based in Paris and was recognised for several years as one of the leading European telecoms analysts.
Latterly, Ian
Growth for outsourcing specialists alldayPA and The Call Centre Group, contact centres for the SME industry, has put the Isher Capital portfolio of contact centre businesses on track to reach its ambitious growth plans, as its turnover swells beyond the GBP30 million milestone.
The Call Centre Group has reported 20 per cent growth over the past twelve months. alldayPA has also reported a successful year with 10 per cent growth, driven by increasing demand from small businesses for outsourced call centre, telephone answering and live chat management.
Isher Capital, which backs both businesses, is aiming to increase its revenue from UK contact
Progressio has completed the sale of Industrie Chimiche Forestali SpA (ICF) to EPS Equita PEP SPAC (EPS).
ICF is a prominent player in adhesives for the footwear, automotive and flexible packaging sectors, with approximately EUR80 million in turnover and a commercial presence in over 70 countries. Founded in 1918, the company turns 100 this year. Since inception ICF has maintained a strong international presence, which was further strengthened by its entry into automotive and flexible packaging adhesives and the special fabrics sector.
The buyer is EPS, a special purpose acquisition company (SPAC), promoted by Equita and Private Equity Partners, and is listed on AIM Italia – Alternative Capital Market. With this acquisition
Hedge fund and private equity administrator, JP Fund Administration (Cayman) Ltd, has grown its Assets Under Administration (AUA) to more than USD5 billion, bringing the JP Integra group total AUA to more than USD6 billion.
Dave van Duynhoven (pictured), head of fund services at JP Integra, says: “2017 was a year of investment in systems and processes to enable us to handle the growing demand for our Cayman based administration services. We passed USD6 billion AUA for the first time and we are excited by prospects in 2018, especially in private equity and investment funds for Family Offices and HNWIs.
Xenikos, a clinical-stage biopharmaceutical company currently developing a novel therapy for treating acute graft-versus-host disease (aGVHD), has secured USD30 million in a Series B financing round.
Two new investors in the company – Medicxi Ventures and RA Capital Management – participated in the financing round. The funds will be used to advance the development of Xenikos’ lead compound, T-Guard, including conducting clinical Phase 3 registration trials in the US and EU, arranging commercial-scale production, and submitting the relevant applications for market approval. In connection with this financing, Dr Jon Edwards of Medicxi and Dr Jake Simson of RA Capital will
Law firm CMS is acting for main market listed ITE Group (ITE) on its proposed GBP300 million acquisition of Ascential’s Exhibitions Business.
The consideration for the acquisition (including estimated costs) is intended to be funded through a GBP315 million rights issue, which has been fully underwritten on a standby basis by Investec Bank plc. ITE is also seeking to increase its debt facilities by GBP50 million with a view to reducing the amount required to be raised by the rights issue to GBP265 million. It is expected that the rights issue will also be underwritten by Numis Securities Limited in due course.
The Gemini Companies (Gemini) has appointed Brian Privor as Chief Regulatory Officer. In this new role, Privor will help ensure that both Gemini and its fund clients’ operations are optimally equipped to comply with rules set by the US Securities and Exchange Commission (SEC), Financial Industry Regulatory Authority (FINRA), National Futures Association (NFA), and other industry regulators.
Privor’s 20 years of professional experience is deeply rooted in asset management and securities regulation, including seven years as Senior Counsel in the SEC’s Asset Management Unit in the Division of Enforcement, and the past year serving on the US Senate Judiciary
Investec Emerging Companies, part of Investec Corporate and Institutional Bank, is launching a fund, INVC, to invest in UK scale-up companies in the fintech and enterprise software sectors.
The fund has a target size of up to USD100 million, and will fill a gap that currently exists between seed and Series A funding rounds. Investec will be the cornerstone investor, accounting for approximately 15 per cent of the fund, with the majority provided by institutional investors and remainder by a small number of private investors.
Three investments already held by Investec Emerging Companies – fintech companies Monese, Curve and
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
